FLT4 and cancer: Collectively, we conclude that Foretinib simultaneously targets cancer cells and LECs to inhibit pancreatic tumor growth and this multiple kinase inhibitor suppresses angiogenesis and lymphangiogenesis by blocking VEGFR-2, VEGFR-3 and TIE-2 signaling.